Pregabalin

Pregabalin Extended Release is a generic prescription drug containing pregabalin, available as oral extended-release tablets in strengths of 82.5 mg, 165 mg, and 330 mg. Manufactured by ScieGen Pharmaceuticals under ANDA215675, it is a controlled substance (Schedule CV) that was marketed starting September 2022 but is now discontinued. This information was generated using AI and is provided for informational and research purposes only.